Delivery Order SPE2DB20D7059-SPE2DB25FPTH1

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,843.61 firm fixed-price delivery order is for the supply of AMNESTEEM 40 MG CAPSULE 30S, with a completion date of December 22, 2022. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,303.02 Firm Fixed Price Delivery Order is for the supply of 4566760674 AMNESTEEM 40 MG CAPSULE 30S, with a performance period running through December 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,103.73 firm fixed-price delivery order contract is for the provision of AMNESTEEM 40 MG CAPSULE 30S medical supplies. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This federal contract award is an order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,142.98 firm fixed-price delivery order is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, to support military healthcare programs. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,383.40 firm-fixed-price delivery order is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a medication, with a performance period through May 1, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,870.24 firm-fixed-price delivery order covers the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, with a completion date of December 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,495.14 Firm Fixed Price Delivery Order contract is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of February 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,685.85 firm fixed-price delivery order is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a medical product. The contract has an ultimate completion date of May 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,401.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of November 8, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,811.13 firm fixed-price delivery order is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a medical product, with a period of performance through February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FPTH1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,813.44 firm fixed-price delivery order is for the supply of the medication AMNESTEEM 40 MG CAPSULE 30S, with an ultimate completion date of October 31, 2024.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities across multiple therapeutic domains. This specific delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 1/29/25, 9:17 AM